CHIU Ricky

Dr. Ricky Chiu

  • Chairman & CEO, PHASE Scientific International Limited

Dr Ricky Chiu is the Founder, Chairman and CEO of PHASE Scientific International Limited, as well as the lead inventor of the Company’s core technology. He has been awarded the Ten Outstanding Young Person of the World, the Ten Outstanding of Young Person in Hong Kong, the InnoStars Award, the Young Industrialist of Hong Kong, the Outstanding Leader – Young Entrepreneur and the HKSAR Chief Executive’s Commendation for Community Service for his outstanding research achievements in biotechnology innovations and his notable contributions to the fight against COVID-19 pandemic.
As a leading innovator in the field of biotechnology, Dr Chiu has made significant breakthroughs and developments in the fields of liquid biopsy and rapid point-of-care testing using the proprietary sample preparation technology he developed. With 46 patents granted, the technology provides an innovative solution to the problem of low-concentration target molecule detection. By concentrating target molecules, such as DNA, RNA, proteins, bacteria, and viruses, the technology improves the performance of diagnostic testing, making it faster, more accurate and more cost-effective.
Dr Chiu is among the few who have received recognition in both the West and the East. From receiving research funding from world-renowned entities and FDA approval to his high-efficiency COVID-19 RNA extraction technology being designated as a “Major Technology” by the Ministry of Science and Technology of China, Dr Chiu’s inventions have positioned him as a changemaker who can uniquely straddle both worlds. He is also a diagnostic policy advocate. His COVID-19 insights have shaped how Hong Kong defend itself against the pandemic.
Dr Chiu is an adjunct associate professor at the School of Biomedical Sciences and the Member of Board of Trustee of the United College of The Chinese University of Hong Kong, as well as the Court Member of The Hong Kong Polytechnic University. He is fully committed to grooming young talents and firmly believes in empowering the next generation to create a positive impact on healthcare globally. Dr Chiu and the PHASE Scientific team are currently engaged in research and product development for the detection of cancer and infectious diseases.